{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T21:12:26Z","timestamp":1784841146620,"version":"3.55.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2008,1,1]],"date-time":"2008-01-01T00:00:00Z","timestamp":1199145600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,1,1]],"date-time":"2008-01-01T00:00:00Z","timestamp":1199145600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2015,4,10]],"date-time":"2015-04-10T00:00:00Z","timestamp":1428624000000},"content-version":"vor","delay-in-days":2656,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["bbmt.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biology of Blood and Marrow Transplantation"],"published-print":{"date-parts":[[2008,1]]},"DOI":"10.1016\/j.bbmt.2007.03.014","type":"journal-article","created":{"date-parts":[[2007,12,28]],"date-time":"2007-12-28T10:51:49Z","timestamp":1198839109000},"page":"59-66","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":83,"title":["Dose-Reduced Busulfan, Cyclophosphamide, and Autologous Stem Cell Transplantation for Human Immunodeficiency Virus\u2013Associated Lymphoma: AIDS Malignancy Consortium Study 020"],"prefix":"10.1016","volume":"14","author":[{"given":"Thomas R.","family":"Spitzer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard F.","family":"Ambinder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeannette Y.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence D.","family":"Kaplan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Wachsman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Straus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M.","family":"Aboulafia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David T.","family":"Scadden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbmt.2007.03.014_bib1","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1056\/NEJM199512073332305","article-title":"Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma","volume":"323","author":"Philip","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bbmt.2007.03.014_bib2","first-page":"310","article-title":"Autologous stem cell transplantation for non-Hodgkin's lymphoma","volume":"2","author":"Lin","year":"2003","journal-title":"Curr Hematol Rep"},{"key":"10.1016\/j.bbmt.2007.03.014_bib3","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1016\/S0140-6736(02)08938-9","article-title":"Aggressive conventional chemotherapy compared with high-dose chemotherapy with autologous haemopoietic stem cell transplantation for relapsed chemosensitive Hodgkin's disease: a randomised trial","volume":"359","author":"Schmitz","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.bbmt.2007.03.014_bib4","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/0140-6736(93)92411-L","article-title":"Dose intensification with autologous bone marrow transplantation in relapsed and resistant Hodgkin's disease: results of a BNLI randomised trial","volume":"341","author":"Linch","year":"1993","journal-title":"Lancet"},{"key":"10.1016\/j.bbmt.2007.03.014_bib5","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1182\/blood-2004-11-4278","article-title":"AIDS-related lymphoproliferative disease","volume":"107","author":"Navarro","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2007.03.014_bib6","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1002\/hon.735","article-title":"The changing face of HIV-associated lymphoma: what can we learn about optimal therapy in the post\u2013highly active antiretroviral therapy era?","volume":"22","author":"Clayton","year":"2004","journal-title":"Hematol Oncol"},{"key":"10.1016\/j.bbmt.2007.03.014_bib7","doi-asserted-by":"crossref","first-page":"265","DOI":"10.7326\/0003-4819-143-4-200508160-00007","article-title":"A prognostic index for systemic AIDS-related non-Hodgkin lymphoma treated in the era of highly active antiretroviral therapy","volume":"143","author":"Bower","year":"2005","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.bbmt.2007.03.014_bib8","doi-asserted-by":"crossref","first-page":"3832","DOI":"10.1182\/blood-2005-09-3600","article-title":"AIDS-related non-Hodgkin's lymphoma: final analysis of 485 patients treated\u00a0with risk-adapted intensive chemotherapy","volume":"107","author":"Mounier","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2007.03.014_bib9","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1182\/blood-2002-03-0989","article-title":"Stanford V regimen and concomitant HAART in 59 patients with Hodgkin disease and HIV infection","volume":"100","author":"Spina","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2007.03.014_bib10","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1002\/cncr.21759","volume":"106","author":"Weiss","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.bbmt.2007.03.014_bib11","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1007\/s11904-005-0008-4","article-title":"Non-AIDS\u2013defining cancers and HIV infection","volume":"2","author":"Lim","year":"2005","journal-title":"Curr HIV\/AIDS Rep"},{"key":"10.1016\/j.bbmt.2007.03.014_bib12","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1182\/blood-2004-12-4729","article-title":"HIV-associated lymphoma: promising new results, but with toxicity","volume":"105","author":"Straus","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2007.03.014_bib13","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1182\/blood-2004-04-1532","article-title":"Durable remissions with autologous stem cell transplantation for high-risk HIV-associated lymphomas","volume":"105","author":"Krishnan","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2007.03.014_bib14","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.exphem.2004.12.008","article-title":"HIV-associated lymphoma successfully treated with peripheral blood stem cell transplantation","volume":"33","author":"Serrano","year":"2005","journal-title":"Exp Hematol"},{"key":"10.1016\/j.bbmt.2007.03.014_bib15","first-page":"1100","article-title":"High-dose therapy plus autologous hematopoietic stem cell transplantation for human immunodeficiency virus (HIV)-related lymphoma: results and impact on HIV disease","volume":"89","author":"Gabarre","year":"2004","journal-title":"Haematologica"},{"key":"10.1016\/j.bbmt.2007.03.014_bib16","doi-asserted-by":"crossref","first-page":"4423","DOI":"10.1200\/JCO.2003.06.039","article-title":"High-dose therapy and autologous peripheral blood stem cell transplantation as salvage treatment for HIV-associated lymphoma in patients receiving highly active antiretroviral therapy","volume":"21","author":"Re","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2007.03.014_bib17","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1038\/sj.cr.7290372","article-title":"AIDS and associated malignancies","volume":"15","author":"Wood","year":"2005","journal-title":"Cell Res"},{"key":"10.1016\/j.bbmt.2007.03.014_bib18","doi-asserted-by":"crossref","first-page":"522a","DOI":"10.1182\/blood.V104.11.1884.1884","article-title":"Dose adjusted busulfan\/cyclophosphamide and autologous stem cell transplantation for recurrent lymphoma","volume":"104","author":"Spitzer","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2007.03.014_bib19","doi-asserted-by":"crossref","first-page":"3835","DOI":"10.1200\/JCO.1999.17.12.3835","article-title":"World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues. Report of the Clinical Advisory Committee meeting, Airlie House, Virginia, November 1997","volume":"17","author":"Harris","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2007.03.014_bib20","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1200\/JCO.1999.17.4.1244","article-title":"Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group","volume":"17","author":"Cheson","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2007.03.014_bib21","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1097\/01.tp.0000168490.29862.b8","article-title":"T-cell immune reconstitution after hematopoietic stem cell transplantation for HIV-associated lymphoma","volume":"80","author":"Benicchi","year":"2005","journal-title":"Transplantation"},{"key":"10.1016\/j.bbmt.2007.03.014_bib22","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1056\/NEJM198312013092202","article-title":"Marrow transplantation for acute nonlymphocytic leukemia after treatment with busulfan and cyclophosphamide","volume":"309","author":"Santos","year":"1983","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bbmt.2007.03.014_bib23","first-page":"12","article-title":"The development of busulfan\/cyclophosphamide preparative regimens","volume":"20","author":"Santos","year":"1993","journal-title":"Semin Oncol"},{"key":"10.1016\/j.bbmt.2007.03.014_bib24","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/BF00694339","article-title":"Pharmacokinetics of busulfan: correlation with veno-occlusive disease in patients undergoing bone marrow transplantation","volume":"25","author":"Grochow","year":"1989","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.bbmt.2007.03.014_bib25","doi-asserted-by":"crossref","first-page":"3055","DOI":"10.1182\/blood.V89.8.3055","article-title":"Marrow transplantation for chronic myeloid leukemia: the influence of plasma busulfan levels on the outcome of transplantation","volume":"89","author":"Slattery","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2007.03.014_bib26","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1038\/sj.leu.2401921","article-title":"A phase I\/II study of multiple-dose intravenous busulfan as myeloablation prior to stem cell transplantation","volume":"14","author":"Olavarria","year":"2000","journal-title":"Leukemia"},{"key":"10.1016\/j.bbmt.2007.03.014_bib27","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1053\/bbmt.2002.v8.pm12374454","volume":"8","author":"Kashyap","year":"2002","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2007.03.014_bib28","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s00277-004-0982-4","article-title":"Decreased incidence of hepatic veno-occlusive disease and fewer hemostatic derangements associated with intravenous busulfan vs oral busulfan in adults conditioned with busulfan + cyclophosphamide for allogeneic bone marrow transplantation","volume":"84","author":"Lee","year":"2005","journal-title":"Ann Hematol"},{"key":"10.1016\/j.bbmt.2007.03.014_bib29","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/S1083-8791(00)70064-4","article-title":"Acute safety and pharmacokinetics of intravenous busulfan when used with oral busulfan and cyclophosphamide as pretransplantation conditioning therapy: a phase I study","volume":"6","author":"Andersson","year":"2000","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2007.03.014_bib30","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/sj.bmt.1703790","article-title":"Busulfan and cyclophosphamide as a preparative regimen for allogeneic blood and marrow transplantation in patients with non-Hodgkin's lymphoma","volume":"31","author":"Kiss","year":"2003","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2007.03.014_bib31","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1038\/sj.bmt.1700733","article-title":"Busulfan and cyclophosphamide (BU\/CY2) as preparative regimen for patients with lymphoma","volume":"19","author":"de Magalhaes-Silverman","year":"1997","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2007.03.014_bib32","first-page":"133","article-title":"Preparation for marrow transplantation in Hodgkin's and non-Hodgkin's lymphoma using Bu\/CY","volume":"12","author":"Avalos","year":"1993","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2007.03.014_bib33","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.bbmt.2003.09.015","article-title":"Autologous transplantation for diffuse aggressive non-Hodgkin lymphoma in first relapse or second remission","volume":"10","author":"Vose","year":"2004","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2007.03.014_bib34","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/sj.bmt.1702796","article-title":"Autotransplants for Hodgkin's disease in first relapse or second remission: a report from the autologous blood and marrow transplant registry (ABMTR)","volume":"27","author":"Lazarus","year":"2001","journal-title":"Bone Marrow Transplant"}],"container-title":["Biology of Blood and Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879107004600?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879107004600?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T14:30:24Z","timestamp":1761057024000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1083879107004600"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,1]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,1]]}},"alternative-id":["S1083879107004600"],"URL":"https:\/\/doi.org\/10.1016\/j.bbmt.2007.03.014","relation":{},"ISSN":["1083-8791"],"issn-type":[{"value":"1083-8791","type":"print"}],"subject":[],"published":{"date-parts":[[2008,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dose-Reduced Busulfan, Cyclophosphamide, and Autologous Stem Cell Transplantation for Human Immunodeficiency Virus\u2013Associated Lymphoma: AIDS Malignancy Consortium Study 020","name":"articletitle","label":"Article Title"},{"value":"Biology of Blood and Marrow Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbmt.2007.03.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 American Society for Blood and Marrow Transplantation. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}